vs
ACACIA RESEARCH CORP（ACTG）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是ACACIA RESEARCH CORP的1.4倍（$69.8M vs $50.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 6.8%，领先377.2%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 2.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 43.6%）
槐亚研究公司是一家总部位于纽约市的美国上市企业，在科技、能源以及工业制造领域开展业务收购与运营工作。该公司与控股股东斯塔博德价值投资合伙企业保持战略伙伴关系，这家企业在业内常被归类为专利流氓。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ACTG vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$50.1M
营收增速更快
RIGL
高出18.6%
2.6%
净利率更高
RIGL
高出377.2%
6.8%
两年增速更快
RIGL
近两年复合增速
43.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $50.1M | $69.8M |
| 净利润 | $3.4M | $268.1M |
| 毛利率 | 12.8% | 91.5% |
| 营业利润率 | -26.1% | 33.2% |
| 净利率 | 6.8% | 384.0% |
| 营收同比 | 2.6% | 21.2% |
| 净利润同比 | 125.5% | 1769.2% |
| 每股收益（稀释后） | $0.03 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACTGRIGL
| Q4 25 | $50.1M | $69.8M | ||
| Q3 25 | $59.4M | $69.5M | ||
| Q2 25 | $51.2M | $101.7M | ||
| Q1 25 | $124.4M | $53.3M | ||
| Q4 24 | $48.8M | $57.6M | ||
| Q3 24 | $23.3M | $55.3M | ||
| Q2 24 | $25.8M | $36.8M | ||
| Q1 24 | $24.3M | $29.5M |
净利润ACTGRIGL
| Q4 25 | $3.4M | $268.1M | ||
| Q3 25 | $-2.7M | $27.9M | ||
| Q2 25 | $-3.3M | $59.6M | ||
| Q1 25 | $24.3M | $11.4M | ||
| Q4 24 | $-13.4M | $14.3M | ||
| Q3 24 | $-14.0M | $12.4M | ||
| Q2 24 | $-8.4M | $-1.0M | ||
| Q1 24 | $-186.0K | $-8.2M |
毛利率ACTGRIGL
| Q4 25 | 12.8% | 91.5% | ||
| Q3 25 | 21.2% | 93.2% | ||
| Q2 25 | 12.8% | 95.6% | ||
| Q1 25 | 47.4% | 91.7% | ||
| Q4 24 | 17.6% | 89.9% | ||
| Q3 24 | 10.1% | 85.5% | ||
| Q2 24 | 26.2% | 92.4% | ||
| Q1 24 | 49.2% | 93.1% |
营业利润率ACTGRIGL
| Q4 25 | -26.1% | 33.2% | ||
| Q3 25 | -10.8% | 40.9% | ||
| Q2 25 | -24.2% | 60.1% | ||
| Q1 25 | 30.8% | 23.9% | ||
| Q4 24 | -32.4% | 28.9% | ||
| Q3 24 | -44.1% | 25.4% | ||
| Q2 24 | -18.4% | 1.2% | ||
| Q1 24 | -8.6% | -23.6% |
净利率ACTGRIGL
| Q4 25 | 6.8% | 384.0% | ||
| Q3 25 | -4.6% | 40.2% | ||
| Q2 25 | -6.4% | 58.6% | ||
| Q1 25 | 19.5% | 21.5% | ||
| Q4 24 | -27.5% | 24.9% | ||
| Q3 24 | -60.0% | 22.5% | ||
| Q2 24 | -32.7% | -2.8% | ||
| Q1 24 | -0.8% | -27.9% |
每股收益（稀释后）ACTGRIGL
| Q4 25 | $0.03 | $14.11 | ||
| Q3 25 | $-0.03 | $1.46 | ||
| Q2 25 | $-0.03 | $3.28 | ||
| Q1 25 | $0.25 | $0.63 | ||
| Q4 24 | $-0.14 | $0.82 | ||
| Q3 24 | $-0.14 | $0.70 | ||
| Q2 24 | $-0.08 | $-0.06 | ||
| Q1 24 | $0.00 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.7M | $155.0M |
| 总债务越低越好 | $91.9M | $52.5M |
| 股东权益账面价值 | $543.5M | $391.5M |
| 总资产 | $771.0M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ACTGRIGL
| Q4 25 | $306.7M | $155.0M | ||
| Q3 25 | $301.8M | $137.1M | ||
| Q2 25 | $316.7M | $108.4M | ||
| Q1 25 | $272.0M | $77.1M | ||
| Q4 24 | $273.9M | $77.3M | ||
| Q3 24 | $410.9M | $61.1M | ||
| Q2 24 | $441.9M | $49.1M | ||
| Q1 24 | $498.4M | $49.5M |
总债务ACTGRIGL
| Q4 25 | $91.9M | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益ACTGRIGL
| Q4 25 | $543.5M | $391.5M | ||
| Q3 25 | $537.6M | $117.6M | ||
| Q2 25 | $538.6M | $81.9M | ||
| Q1 25 | $540.2M | $18.6M | ||
| Q4 24 | $514.8M | $3.3M | ||
| Q3 24 | $540.2M | $-14.6M | ||
| Q2 24 | $560.7M | $-29.9M | ||
| Q1 24 | $568.3M | $-31.7M |
总资产ACTGRIGL
| Q4 25 | $771.0M | $513.6M | ||
| Q3 25 | $768.9M | $242.5M | ||
| Q2 25 | $775.5M | $206.7M | ||
| Q1 25 | $801.6M | $176.0M | ||
| Q4 24 | $756.4M | $164.0M | ||
| Q3 24 | $707.6M | $139.4M | ||
| Q2 24 | $753.6M | $128.4M | ||
| Q1 24 | $631.7M | $126.5M |
负债/权益比ACTGRIGL
| Q4 25 | 0.17× | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 22.01× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACTGRIGL
| Q4 25 | $75.2M | $22.0M | ||
| Q3 25 | $9.5M | $24.0M | ||
| Q2 25 | $50.1M | $30.5M | ||
| Q1 25 | $2.4M | $-893.0K | ||
| Q4 24 | $50.1M | $14.5M | ||
| Q3 24 | $-593.0K | $21.7M | ||
| Q2 24 | $16.1M | $302.0K | ||
| Q1 24 | $54.8M | $-5.0M |
自由现金流ACTGRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $335.0K | — | ||
| Q4 24 | $-98.5M | — | ||
| Q3 24 | $-2.8M | — | ||
| Q2 24 | $-126.7M | — | ||
| Q1 24 | $54.6M | — |
自由现金流率ACTGRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | -201.8% | — | ||
| Q3 24 | -12.1% | — | ||
| Q2 24 | -490.5% | — | ||
| Q1 24 | 224.4% | — |
资本支出强度ACTGRIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 304.4% | — | ||
| Q3 24 | 9.6% | — | ||
| Q2 24 | 553.0% | — | ||
| Q1 24 | 1.1% | — |
现金转化率ACTGRIGL
| Q4 25 | 22.01× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 0.10× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
RIGL
暂无分部数据
